No I am not yanking your chain. Allow me a minute to explain.
Within a series of FCC files pertaining to testing for the Apple iPhone, I've just found a document sent May 18 from Robert Steinfeld, EMC & Wireless Compliance Manager at Apple, to Compliance Engineering Services of Fremont, Cal.
Posted on the FCC site June 15, the letter refers to engaging the company to "act on our behalf in all manners relating to application for equipment authorization, including signing of all documents relating to these matters. Any and all acts carried out by CCS on our behalf shall have the same effect as acts of our own."
These "acts" include submission of files containing test results for wireless equipment Apple seeks FCC certification for, and to then sell.
Hmm, can you think of a product that fits that description?
OK, now to the drug thing.
The letter from Apple to Compliance Engineering Services, contains this short caveat:
We, the undersigned, hereby certify that we are not subject to a denial of federal benefits, that includes FCC benefits, pursuant to Section 5301 of the Anti-Drug Abuse Act of 1988, 21 U.S.C. 853 (a).
What's being referred to here is an act conferring discretionary power to judges that enable them to deny certain privileges to convicted drug "distributors." That would mean working on products that are subject to the FCC's approval process.
Nice to know that presumably, the only drug the iPhone developers were "on" was caffeine.